Literature DB >> 23377618

3D organotypic cultures of human HepaRG cells: a tool for in vitro toxicity studies.

Patrina Gunness1, Daniel Mueller, Valery Shevchenko, Elmar Heinzle, Magnus Ingelman-Sundberg, Fozia Noor.   

Abstract

Drug-induced human hepatotoxicity is difficult to predict using the current in vitro systems. In this study, long-term 3D organotypic cultures of the human hepatoma HepaRG cell line were prepared using a high-throughput hanging drop method. The organotypic cultures were maintained for 3 weeks and assessed for (1) liver specific functions, including phase I enzyme and transporter activities, (2) expression of liver-specific proteins, and (3) responses to three drugs (acetaminophen, troglitazone, and rosiglitazone). Our results show that the organotypic cultures maintain high liver-specific functionality during 3 weeks of culture. The immunohistochemistry analyses illustrate that the organotypic cultures express liver-specific markers such as albumin, CYP3A4, CYP2E1, and MRP-2 throughout the cultivation period. Accordingly, the production rates of albumin and glucose, as well as CYP2E1 activity, were significantly higher in the 3D versus the 2D cultures. Toxicity studies show that the organotypic cultures are more sensitive to acetaminophen- and rosiglitazone-induced toxicity but less sensitive to troglitazone-induced toxicity than the 2D cultures. Furthermore, the EC50 value (2.7mM) for acetaminophen on the 3D cultures was similar to in vivo toxicity. In summary, the results from our study suggest that the 3D organotypic HepaRG culture is a promising in vitro tool for more accurate assessment of acute and also possibly for chronic drug-induced hepatotoxicity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23377618     DOI: 10.1093/toxsci/kft021

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  56 in total

1.  From the Cover: Three-Dimensional (3D) HepaRG Spheroid Model With Physiologically Relevant Xenobiotic Metabolism Competence and Hepatocyte Functionality for Liver Toxicity Screening.

Authors:  Sreenivasa C Ramaiahgari; Suramya Waidyanatha; Darlene Dixon; Michael J DeVito; Richard S Paules; Stephen S Ferguson
Journal:  Toxicol Sci       Date:  2017-09-01       Impact factor: 4.849

Review 2.  Pregnane X receptor and drug-induced liver injury.

Authors:  Yue-Ming Wang; Sergio C Chai; Christopher T Brewer; Taosheng Chen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2014-09-25       Impact factor: 4.481

Review 3.  Assembly of human organs from stem cells to study liver disease.

Authors:  Kan Handa; Kentaro Matsubara; Ken Fukumitsu; Jorge Guzman-Lepe; Alicia Watson; Alejandro Soto-Gutierrez
Journal:  Am J Pathol       Date:  2013-12-12       Impact factor: 4.307

Review 4.  Liver 'organ on a chip'.

Authors:  Colin H Beckwitt; Amanda M Clark; Sarah Wheeler; D Lansing Taylor; Donna B Stolz; Linda Griffith; Alan Wells
Journal:  Exp Cell Res       Date:  2017-12-29       Impact factor: 3.905

5.  High-content imaging assays on a miniaturized 3D cell culture platform.

Authors:  Pranav Joshi; Akshata Datar; Kyeong-Nam Yu; Soo-Yeon Kang; Moo-Yeal Lee
Journal:  Toxicol In Vitro       Date:  2018-03-06       Impact factor: 3.500

6.  A 3D fish liver model for aquatic toxicology: Morphological changes and Cyp1a induction in PLHC-1 microtissues after repeated benzo(a)pyrene exposures.

Authors:  April L Rodd; Norma J Messier; Charles A Vaslet; Agnes B Kane
Journal:  Aquat Toxicol       Date:  2017-02-21       Impact factor: 4.964

Review 7.  A shift in paradigm towards human biology-based systems for cholestatic-liver diseases.

Authors:  Fozia Noor
Journal:  J Physiol       Date:  2015-11-04       Impact factor: 5.182

Review 8.  High-throughput imaging: Focusing in on drug discovery in 3D.

Authors:  Linfeng Li; Qiong Zhou; Ty C Voss; Kevin L Quick; Daniel V LaBarbera
Journal:  Methods       Date:  2015-11-21       Impact factor: 3.608

9.  SpheroidChip: Patterned Agarose Microwell Compartments Harboring HepG2 Spheroids are Compatible with Genotoxicity Testing.

Authors:  Christy Chao; P Ngo Le; Bevin P Engelward
Journal:  ACS Biomater Sci Eng       Date:  2020-03-02

Review 10.  State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology.

Authors:  Natalie Alépée; Anthony Bahinski; Mardas Daneshian; Bart De Wever; Ellen Fritsche; Alan Goldberg; Jan Hansmann; Thomas Hartung; John Haycock; Helena Hogberg; Lisa Hoelting; Jens M Kelm; Suzanne Kadereit; Emily McVey; Robert Landsiedel; Marcel Leist; Marc Lübberstedt; Fozia Noor; Christian Pellevoisin; Dirk Petersohn; Uwe Pfannenbecker; Kerstin Reisinger; Tzutzuy Ramirez; Barbara Rothen-Rutishauser; Monika Schäfer-Korting; Katrin Zeilinger; Marie-Gabriele Zurich
Journal:  ALTEX       Date:  2014-07-14       Impact factor: 6.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.